• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number C132 - KIT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Respiratory Failure (2484)
Event Date 02/15/2015
Event Type  Death  
Event Description
Received notification related to tc-v, on (b)(6) 2015 from (b)(4) study sponsor that patient (b)(6) had an adverse event.Event details are as follows: respiration failure on (b)(6) 2015, considered life threatening.As of (b)(6) 2015, patient had not recovered from event.(b)(6) 2015: icf was taken, cgvhd score/lung: 3 bo.(b)(6) 2015: tc-v started.(b)(6) 2015: ground-glass appearance, thickened wall, and partial consolidation were found in both superior lobe of the lung and s3 by ct.(b)(6) 2015: disturbance of consciousness in early morning by blood gas exam, co2 narcosis, she was treated with a ventilator, started antibiotics and steroid pulse therapy due to worsening lung gvhd and respiration failure.Methylprednisolone sodium succinate iv 500mg.Cravit drop infusion intravenous pack 500mg.Humilin r vial for steroid dm.She showed improvement on co2 narcosis and conscious level.(b)(6) 2015: effort respiration continuing.Judged to determinate the clinical trial.(b)(4).Since her lung inflammation was caused by infectivity as cghvd and steroid treatment, the reporter does not think there is relation between sae and ecp treatment.Information related to treatment is from treatment date of (b)(6) 2015.No product will be returned.
 
Manufacturer Narrative
A review of lot c132 was performed and there were no non-conformances for this lot.This lot met all release requirements.Trends were reviewed for events related to this complaint and there were no trend detected.The assessment is based on information available at the time of the investigation.The patient's respiratory failure was mos likely related to the patient's underlying condition; however, since the patient required medical intervention, this case is serious and was assessed as reportable.(b)(4).
 
Manufacturer Narrative
(b)(6) 2015: effort respiration continuing.Judged to terminate the clinical trial for patient.(b)(6) 2015: physician stated patient has recovered from infection.Patient is stable at this time.March 25, 2015: received information from (b)(6) hospital that patient (b)(6)expired on (b)(6) 2015.(b)(6) female with pulmonary gvhd and pneumonia died of cardiac arrest on (b)(6) 2015.The patient's last procedure was (b)(6) 2015.Patient was taken off ecp clinical trial on (b)(6) 2015.The death occurred one month and 4 days after the patient was taken off the clinical trial.Attending physician assessed this case as "the relation between death and the clinical trial is denied." uvadex was administered while the patient was on the trial, however this case has no relationship to uvadex, because there is no temporal relationship.This case has no relation to ecp procedure as the cause of the death is due to the patient's underlying condition.This case is serious, unrelated and reportable as a supplemental report.The patient was first hospitalized for respiratory failure due to the patient's underlying condition.Patient's condition worsened and passed away about 6 weeks after first hospitalization.There is no evidence of device malfunction.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS INC
west chester PA
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 bailey avenue
buffalo NY 14211
Manufacturer Contact
dianna inguanzo
10 north high street
suite 300
west chester, PA 19380
MDR Report Key4584677
MDR Text Key5481947
Report Number2523595-2015-00052
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/16/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/01/2016
Device Lot NumberC132 - KIT
Other Device ID Number10705030100009
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/16/2015
Initial Date FDA Received03/09/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/10/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age60 YR
Patient Weight30
-
-